| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |